Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhuoli Zhang

Showing results (1-10 of 390) with videos related to

Pageof 39
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|March 21, 2023
Disease activity and health-related quality of life among patients with rheumatoid arthritis with different alcohol consumption habits: comment on the article by Alfredsson et alWenhui Xie, Zhuoli Zhang
Annals of the Rheumatic Diseases|April 26, 2020
Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopaenic purpuraWenhui Xie, Zhuoli Zhang
Clinical Rheumatology|December 8, 2022
Effective therapy of pirfenidone in a patient with idiopathic retroperitoneal fibrosis: report of a caseJuan Zhao, Zhuoli Zhang
Annals of the Rheumatic Diseases|November 4, 2020
Correspondence on 'Increased risk of systemic lupus erythematosus in patients with autoimmune haemolytic anaemia'Hong Huang, Zhuoli Zhang
Rheumatology (Oxford, England)|May 1, 2020
Comment on: Relapse predictors and serologically unstable condition of IgG4-related disease: predictors for relapse of IgG4-RDWenhui Xie, Zhuoli Zhang
Arthritis & Rheumatology (Hoboken, N.J.)|April 7, 2020
Classifying Remission in Rheumatoid Arthritis Treat-to-Target Studies: Comment on the Article by Norvang et alWenhui Xie, Zhuoli Zhang
Rheumatology (Oxford, England)|March 13, 2020
Tofacitinib in cardiovascular outcomes: friend or foe?Wenhui Xie, Zhuoli Zhang
Clinical Rheumatology|March 25, 2020
The predictive value of serum soluble ICAM-1 and CXCL13 in the therapeutic response to TNF inhibitor in rheumatoid arthritis patients who are refractory to csDMARDsJuan Zhao, Xia Ye, Zhuoli Zhang
Advances in Rheumatology (London, England)|June 20, 2022
Syndecan-4 is correlated with disease activity and serological characteristic of rheumatoid arthritisJuan Zhao, Xia Ye, Zhuoli Zhang
Seminars in Arthritis and Rheumatism|September 10, 2020
Efficacy and safety of sirolimus in patients with systemic lupus erythematosus: A systematic review and meta-analysisLanlan Ji, Wenhui Xie, Zhuoli Zhang
Pageof 39

Showing results (1-10 of 390) with videos related to

Sort By:
Pageof 39
Arthritis & Rheumatology (Hoboken, N.J.)|March 21, 2023
Disease activity and health-related quality of life among patients with rheumatoid arthritis with different alcohol consumption habits: comment on the article by Alfredsson et alWenhui Xie, Zhuoli Zhang
Annals of the Rheumatic Diseases|April 26, 2020
Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopaenic purpuraWenhui Xie, Zhuoli Zhang
Clinical Rheumatology|December 8, 2022
Effective therapy of pirfenidone in a patient with idiopathic retroperitoneal fibrosis: report of a caseJuan Zhao, Zhuoli Zhang
Annals of the Rheumatic Diseases|November 4, 2020
Correspondence on 'Increased risk of systemic lupus erythematosus in patients with autoimmune haemolytic anaemia'Hong Huang, Zhuoli Zhang
Rheumatology (Oxford, England)|May 1, 2020
Comment on: Relapse predictors and serologically unstable condition of IgG4-related disease: predictors for relapse of IgG4-RDWenhui Xie, Zhuoli Zhang
Arthritis & Rheumatology (Hoboken, N.J.)|April 7, 2020
Classifying Remission in Rheumatoid Arthritis Treat-to-Target Studies: Comment on the Article by Norvang et alWenhui Xie, Zhuoli Zhang
Rheumatology (Oxford, England)|March 13, 2020
Tofacitinib in cardiovascular outcomes: friend or foe?Wenhui Xie, Zhuoli Zhang
Clinical Rheumatology|March 25, 2020
The predictive value of serum soluble ICAM-1 and CXCL13 in the therapeutic response to TNF inhibitor in rheumatoid arthritis patients who are refractory to csDMARDsJuan Zhao, Xia Ye, Zhuoli Zhang
Advances in Rheumatology (London, England)|June 20, 2022
Syndecan-4 is correlated with disease activity and serological characteristic of rheumatoid arthritisJuan Zhao, Xia Ye, Zhuoli Zhang
Seminars in Arthritis and Rheumatism|September 10, 2020
Efficacy and safety of sirolimus in patients with systemic lupus erythematosus: A systematic review and meta-analysisLanlan Ji, Wenhui Xie, Zhuoli Zhang
Pageof 39